ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.935
      0.18%
      Bitcoin
      65,016.92
      -0.19%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mind Medicine MindMed Inc (MNMD)

      7. Mind Medicine MindMed Inc (MNMD) News

      MNMD

      Mind Medicine MindMed (MNMD)

      Mind Medicine MindMed Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MNMD
      DateTimeSourceHeadlineSymbolCompany
      10/06/20221:34PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MNMDMind Medicine MindMed Inc
      10/05/20228:35AMPR Newswire (Canada)MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
      10/05/20228:35AMPR Newswire (US)MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
      10/04/20227:30AMPR Newswire (Canada)MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMANASDAQ:MNMDMind Medicine MindMed Inc
      10/04/20227:30AMPR Newswire (US)MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMANASDAQ:MNMDMind Medicine MindMed Inc
      09/29/20224:30PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNMDMind Medicine MindMed Inc
      09/29/20224:27PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MNMDMind Medicine MindMed Inc
      09/28/20223:52PMPR Newswire (US)MindMed Board is Trippin': Significant Investor Calls for Termination of Highly Dilutive Equity Offering and Pledges to Hold Board and Management Accountable through Activist CampaignNASDAQ:MNMDMind Medicine MindMed Inc
      09/27/202211:47PMPR Newswire (US)MindMed Announces Pricing of Public Offering of Common Shares and WarrantsNASDAQ:MNMDMind Medicine MindMed Inc
      09/27/202211:47PMPR Newswire (Canada)MindMed Announces Pricing of Public Offering of Common Shares and WarrantsNASDAQ:MNMDMind Medicine MindMed Inc
      09/27/20226:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNMDMind Medicine MindMed Inc
      09/27/20224:24PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MNMDMind Medicine MindMed Inc
      09/27/20224:17PMPR Newswire (US)MindMed Announces Proposed Public Offering of Common SharesNASDAQ:MNMDMind Medicine MindMed Inc
      09/27/20224:17PMPR Newswire (Canada)MindMed Announces Proposed Public Offering of Common SharesNASDAQ:MNMDMind Medicine MindMed Inc
      09/20/20227:30AMPR Newswire (US)MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like SubstancesNASDAQ:MNMDMind Medicine MindMed Inc
      09/20/20227:30AMPR Newswire (Canada)MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like SubstancesNASDAQ:MNMDMind Medicine MindMed Inc
      09/19/202212:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNMDMind Medicine MindMed Inc
      09/14/20228:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNMDMind Medicine MindMed Inc
      09/14/20227:30AMPR Newswire (US)MindMed Announces Compliance with Nasdaq Listing RequirementsNASDAQ:MNMDMind Medicine MindMed Inc
      09/14/20227:30AMPR Newswire (Canada)MindMed Announces Compliance with Nasdaq Listing RequirementsNASDAQ:MNMDMind Medicine MindMed Inc
      09/08/20227:30AMPR Newswire (Canada)MindMed Announces Positive Results from Collaborators' Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed JournalNASDAQ:MNMDMind Medicine MindMed Inc
      09/08/20227:30AMPR Newswire (US)MindMed Announces Positive Results from Collaborators' Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed JournalNASDAQ:MNMDMind Medicine MindMed Inc
      09/07/20227:30AMPR Newswire (Canada)MindMed to Participate in H.C. Wainwright Global Investment ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
      09/07/20227:30AMPR Newswire (US)MindMed to Participate in H.C. Wainwright Global Investment ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
      09/01/202212:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNMDMind Medicine MindMed Inc
      09/01/202212:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNMDMind Medicine MindMed Inc
      08/26/20224:48PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNMDMind Medicine MindMed Inc
      08/26/20224:30PMPR Newswire (Canada)MindMed Completes 1-for-15 Reverse Share SplitNASDAQ:MNMDMind Medicine MindMed Inc
      08/26/20224:30PMPR Newswire (US)MindMed Completes 1-for-15 Reverse Share SplitNASDAQ:MNMDMind Medicine MindMed Inc
      08/25/20227:30AMPR Newswire (US)MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety DisorderNASDAQ:MNMDMind Medicine MindMed Inc
       Showing the most relevant articles for your search:NASDAQ:MNMD